Page last updated: 2024-08-21

formestane and Metastase

formestane has been researched along with Metastase in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's9 (69.23)18.2507
2000's3 (23.08)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, Z; Liu, X; Song, S; Wang, T; Wu, S; Yu, J1
Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R1
Dowsett, M; Jacobs, S; Lonning, PE; MacNeill, FA; Powles, TJ1
Murray, R; Pitt, P1
Attili, A; Bajetta, E; Bartoli, C; Buzzoni, R; Ferrari, L; Lepera, P; Martinetti, A; Noberasco, C; Sacchini, V; Zilembo, N1
Alberola Candel, V; Calabresi, F; Delozier, T; Feuilhade, F; Freue, M; Goss, P; Mauriac, L; Michel, RT; Pérez Carrión, R; Santos, R1
Höffken, K; Jonat, W; Possinger, K1
Bajetta, E; Buzzoni, R; Celio, L; Cerrotta, AM; Ferrari, L; Galante, E; Martinetti, A; Noberasco, C; Orefice, S; Zilembo, N1
Rose, C1
Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B1
Alonso, MC; Español, I; Muñíz-Díaz, E; Pujol-Moix, N1
Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; Makinde, V; McConkey, C; Quilliam, J; Sutcliffe, R1
Brodie, AM; Coombes, RC; Cunningham, D; Dowsett, M; Ford, HT; Gazet, JC; Hutchison, G; Powles, TJ1

Reviews

1 review(s) available for formestane and Metastase

ArticleYear
Proper sequence of endocrine therapies in advanced breast cancer.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35 Suppl 5

    Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Premenopause

1996

Trials

9 trial(s) available for formestane and Metastase

ArticleYear
[Clinical trial of lentaron for postmenopausal patients with advanced breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2002, Volume: 24, Issue:5

    Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Treatment Outcome

2002
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:1

    Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2003
The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Postmenopause

1995
Formestane: effective therapy in postmenopausal women with advanced breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7

    Topics: 17-Hydroxycorticosteroids; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen

1994
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7

    Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen

1994
Formestane in the treatment of advanced postmenopausal breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7

    Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Injections, Intramuscular; Middle Aged; Neoplasm Metastasis; Postmenopause; Remission Induction

1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.
    Breast cancer research and treatment, 1994, Volume: 30, Issue:2

    Topics: Aged; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Neoplasm Metastasis; Postmenopause; Time Factors

1994
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure

1997
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:5

    Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Metastasis; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Survival Analysis

2001

Other Studies

3 other study(ies) available for formestane and Metastase

ArticleYear
Treatment of advanced breast cancer with formestane.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7

    Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission Induction; Survival Analysis

1994
Severe immune thrombocytopenia during formestane treatment.
    Haematologica, 1998, Volume: 83, Issue:10

    Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Thrombocytopenia

1998
Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:3

    Topics: Administration, Oral; Adult; Aged; Androstenedione; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Ovariectomy

1987